Long-Term Tolvaptan Treatment in Refractory Heart Failure

Overview of attention for article published in Circulation Reports, September 2019

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway

Article in Journal of Ethnopharmacology (April 2024)

Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan

Article in Journal of Cardiology (December 2022)

Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age

Article in BMC Cardiovascular Disorders (April 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.